Fred Weiss Net Worth

Fred Weiss biography

Fred Weiss serves as Independent Director of the Company. Mr. Weiss is currently the managing director of the consulting firm FGW Consultancy LLC and was previously the managing director of FGW Associates, Inc., a position he held beginning in 1997. Prior to joining FGW Associates, Inc., he served as a senior executive for Warner-Lambert for nearly 20 years. Mr. Weiss has been on the board of directors and Chair of the Finance Committee of the Michael J. Fox Foundation for Parkinson's Research since 2000. From 2001 to 2007 Mr. Weiss was a member of the BTG plc board of directors and Chair of the Audit Committee. Mr. Weiss served from 2000 to January 2017 as Vice Chair of the board of directors and Chair of the Audit Committee of numerous BlackRock-sponsored mutual funds. He also served on the board of directors of Allergan plc from 2000 to 2018. Mr. Weiss is being nominated to serve on our board of directors because of his financial expertise and experience in strategic planning and corporate development.

What is the salary of Fred Weiss?

As the Independent Director of Osmotica Pharmaceuticals Plc, the total compensation of Fred Weiss at Osmotica Pharmaceuticals Plc is $462,911. There are 9 executives at Osmotica Pharmaceuticals Plc getting paid more, with Brian Markison having the highest compensation of $4,338,620.

How old is Fred Weiss?

Fred Weiss is 78, he's been the Independent Director of Osmotica Pharmaceuticals Plc since 2018. There are no older and 16 younger executives at Osmotica Pharmaceuticals Plc.

What's Fred Weiss's mailing address?

Fred's mailing address filed with the SEC is C/O OSMOTICA PHARMACEUTICALS PLC, 400 CROSSING BOULEVARD, BRIDGEWATER, NJ, 08807.

Insiders trading at Osmotica Pharmaceuticals Plc

Over the last 6 years, insiders at Osmotica Pharmaceuticals Plc have traded over $0 worth of Osmotica Pharmaceuticals Plc stock and bought 6,343,800 units worth $31,350,366 . The most active insiders traders include David F Burgstahler, Sriram Venkataraman и Ltd Orbit Co Invest A 1 Llc.... On average, Osmotica Pharmaceuticals Plc executives and independent directors trade stock every 117 days with the average trade being worth of $1,173,603. The most recent stock trade was executed by James Schaub on 16 December 2021, trading 93,800 units of OSMT stock currently worth $100,366.

What does Osmotica Pharmaceuticals Plc do?

Osmotica Pharmaceuticals plc is a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations. The company has a diverse portfolio consisting of promoted and non-promoted products, several of which incorporate Osmotica’s proprietary Osmodex® drug delivery system. RVL Pharmaceuticals, Inc. is the Company’s ophthalmic subsidiary supporting Upneeq®. Vertical Pharmaceuticals, LLC represents the Company’s diversified branded portfolio and Trigen Laboratories, LLC represents the Company’s non-promoted products, including complex generic formulations. Osmotica has operations in the United States, Argentina, and Hungary.

Osmotica Pharmaceuticals Plc executives and stock owners

Osmotica Pharmaceuticals Plc executives and other stock owners filed with the SEC include:

• Brian Markison,
  Chairman of the Board, Chief Executive Officer
• Christopher Klein,
  General Counsel, Secretary
• Tina deVries,
  Executive Vice President - Research & Development
• James Schaub,
  Chief Operating Officer, Executive Vice President
• Brian A. Markison,
  Chairman, Pres & CEO
• Christopher A. Klein,
  Gen. Counsel & Sec.
• James D. Schaub,
  Exec. VP & COO
• Dr. Tina Marie deVries,
  Exec. VP of R&D
• Andrew Einhorn,
  Chief Financial Officer
• Fred Weiss,
  Independent Director
• Gregory Cowan,
  Independent Director
• David Burgstahler,
  Director
• Sriram Venkataraman,
  Director
• Juan Vergez,
  Director
• Michael DeBiasi,
  Independent Director
• Lisa Wilson,
  IR Contact Officer
• Joachim Benes,
  Director
• Andrew J. Einhorn CPA,
  Chief Financial Officer
• Jarret Miller,
  Exec. VP of HR
• Sergio Alegre,
  VP of Global Compliance
• Capital Partners Iii Gp, L....,
  
• Ltd Orbit Co Invest A 1 Llc...,
  
• Foundation Harsaul,
  10% owner
• Capital Partners Iii Gp, L....,